Blue Water Vaccines Pronounces Institutional Analysis Protection by Two Notable Healthcare-Centered Wall Road Banks, Receives “Purchase” Score From Each
CINCINNATI, Dec. 12, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Firm”), a biopharmaceutical firm growing transformational vaccines to handle important international well being challenges, immediately introduced its first analyst protection since going public in February 2022 with the preliminary suggestions as “purchase” from each Maxim Group LLC […]
Continue Reading